| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T58 |
0-102 |
Sentence |
denotes |
Remdesivir is an adenosine monophosphate derivative and nucleotide-based antiviral prodrug (Figure 2). |
| T59 |
103-181 |
Sentence |
denotes |
Remdesivir received, in May 2020, an emergency use authorization from the U.S. |
| T60 |
182-319 |
Sentence |
denotes |
FDA for the treatment of laboratory-confirmed or suspected COVID-19 illness in children and adults hospitalized with severe disease [25]. |
| T61 |
320-447 |
Sentence |
denotes |
The parenterally administered drug is being developed by Gilead Sciences, U.S., and has broad-spectrum antiviral activity [26]. |
| T62 |
448-523 |
Sentence |
denotes |
It was first studied in 2016 as a potential treatment for Ebola virus [27]. |
| T63 |
524-692 |
Sentence |
denotes |
In addition to its activity against SARS-CoV-2, remdesivir has a potential to treat a variety of infections caused by RNA viruses, including SARS-CoV and MERS-CoV [28]. |
